ASX Share rice
Tue 27 Oct 2020 - 06:13:pm (Sydney)

IVQ Share Price

INVITROCUE LIMITEDIVQPharmaceuticals, Biotechnology & Life Sciences

IVQ Company Information

Name:

Invitrocue Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Biotechnology

GIC Sub Industry:

Biotechnology

Address:

11 Biopolis Way Singapore Singapore 138667

Phone:

65 6460 0497

Founder, MD & Exec. Chairman:

Dr. Boon Sing Fang

CEO of Europe & Director:

Dr. Andreas Lindner

Company Sec. & Non-Exec. Director:

Mr. Chow-Yee Koh

VP of Operation:

Mr. Martin D. Bach

Scientific Consultant:

Prof. Arial Zeng Yi

Company Overview:

Invitrocue Limited engages in the research and experimental development on biotechnology, life, and medical science primarily in Singapore, Australia, China, Hong Kong, and Germany. The company develops Onco Patient-Derived Organoid (PDO) test, a personalized cancer treatment for cancer patients; and 3D CelluSponge series, a 3D in-vitro platform technology for various applications, including 3D cell culture, hepatocyte culture, in-vitro drug metabolism and pharmacokinetics assays and toxicology, stem cell differentiation, PDO, and pathogen infection and detection. It also provides respiratory disease, and customized assays and disease modelling services. Invitrocue Limited was founded in 2012 and is headquartered in Singapore.

IVQ Share Price Information

Shares Issued:

578.49M

Market Capitalisation:

$34.71M

Earnings per Share:

$-0.007

Return On Assets (TTM):

$-1.67

Return On Equity (TTM):

$-12.14

Quarterly Revenue Growth (YOY):

0.06

Gross Profit(TTM):

$252.86K

Diluted Earnings Per Share (TTM):

$-0.007

IVQ CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-156,721.45

Change To Liabilities:

$391.72K

Total Cashflow From Investing Activities:

$-148,760

Net Borrowings:

$1.04M

Net Income:

$-7,025,397.18

Total Cash From Operating Activities:

$-3,866,890

Depreciation:

$77.51K

Other Cashflow From Investing Activities:

$41.26K

Change To Inventory:

$-47,926

Change To Account Receivables:

$250.57K

Sale Purchase Of Stock:

$0.98M

Capital Expenditures:

$190.02K

IVQ Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-6,651,880

Net Income:

$-6,668,510

Gross Profit:

$255.39K

Operating Income:

$-6,651,880

Interest Expense:

$42.85K

Income Tax Expense:

$2.20K

Total Revenue:

$541.87K

Total Operating Expenses:

$7.48M

Cost Of Revenue:

$286.48K

IVQ Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$184.42K

Total Liabilities:

$2.72M

Total Stockholder Equity:

$-1,301,970

Other Current Liabilities:

$501.51K

Total Assets:

$1.42M

Common Stock:

$29.21M

Other Current Assets:

$82.85K

Retained Earnings:

$-30,795,520

Other Liabilities:

$2.58K

Other Assets:

$61.62K

Cash:

$361.11K

Total Current Liabilities:

$2.32M

Short-Term Debt:

$500.79K

Property - Plant & Equipment:

$160.26K

Net Tangible Assets:

$-1,424,769

Total Current Assets:

$1.07M

Long-Term Debt:

$337.99K

Net Receivables:

$281.13K

Short-Term Investments:

$363.13K

Inventory:

$230.10K

Accounts Payable:

$464.22K

Non Currrent Assets (Other):

$363.13K

Short-Term Investments:

$363.13

Non Current Liabilities (Other):

$358.80K

Non Current Liabilities Total:

$358.80K

IVQ Share Price History

IVQ News